Publications by authors named "Js Bevan"

Claim this Profile
M
MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post-hoc analysis.
Fabrice Bonneville, Louis-David Rivière, Stephan Petersenn, Js Bevan, Aude Houchard

Eur J Endocrinol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study.
Enrique Soto-Pedre, Paul J Newey, John S Bevan, Graham P Leese

Endocr Connect· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study.
Philippe J Caron, Stephan Petersenn, Aude Houchard, Caroline Sert, John S Bevan

Clin Endocrinol (Oxf)· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS).
Enrique Soto-Pedre, Paul J Newey, John S Bevan, Neil Greig, Graham P Leese

Clin Endocrinol (Oxf)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline.
William M Drake, Craig E Stiles, John S Bevan, Niki Karavitaki, Peter J Trainer

J Clin Endocrinol Metab· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
Philippe J Caron, John S Bevan, Stephan Petersenn, Aude Houchard, Caroline Sert

Pituitary· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An audit of the management of childhood-onset growth hormone deficiency during young adulthood in Scotland.
M Ahmid, V Fisher, A J Graveling, S McGeoch, E McNeil, J S Bevan

Int J Pediatr Endocrinol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study.
Andrea Giustina, John S Bevan, Marcello D Bronstein, Felipe F Casanueva, Philippe Chanson

Pituitary· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
Judit Dénes, Francesca Swords, Eleanor Rattenberry, Karen Stals, Martina Owens, John S Bevan

J Clin Endocrinol Metab· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long?
Jubbin J Jacob, John S Bevan

Clin Endocrinol (Oxf)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database.
Hannah M A Robertson, Anil K P Narayanaswamy, Olivia Pereira, Shirley A Copland, Richard Herriot, John S Bevan

Thyroid· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3).
Angela Rogers, M Andrew Nesbit, Fadil M Hannan, Sarah A Howles, Caroline M Gorvin, John S Bevan

J Clin Endocrinol Metab· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.
Philippe J Caron, John S Bevan, Stephan Petersenn, Daniel Flanagan, Antoine Tabarin

J Clin Endocrinol Metab· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 drug hypersensitivity following first dose of pegvisomant.
Jubbin J Jacob, John S Bevan

Clin Endocrinol (Oxf)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists.
W M Drake, C E Stiles, T A Howlett, A A Toogood, J S Bevan

J Clin Endocrinol Metab· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pituitary incidentaloma.
John S Bevan

Clin Med (Lond)· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia.
S C McGeoch, S Olson, Z H Krukowski, J S Bevan

J Clin Endocrinol Metab· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithyroid drug regimen for treating Graves' hyperthyroidism.
Prakash Abraham, Alison Avenell, Susan C McGeoch, Louise F Clark, John S Bevan

Cochrane Database Syst Rev· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative assessment for pituitary surgery.
Olivia Pereira, John S Bevan

Pituitary· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
Shamasunder H Acharya, Alison Avenell, Sam Philip, Jennifer Burr, John S Bevan

Clin Endocrinol (Oxf)· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home administration of lanreotide Autogel by patients with acromegaly, or their partners, is safe and effective.
J S Bevan, J Newell-Price, J A H Wass, S L Atkin, P M Bouloux

Clin Endocrinol (Oxf)· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is annual surveillance of all treated hypothyroid patients necessary?
Ananth K Viswanath, Alison Avenell, Sam Philip, Shamsunder H Acharya, Graeme Maclennan, John S Bevan

BMC Endocr Disord· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can dopamine agonists prevent postoperative remnant enlargement in nonfunctioning pituitary adenomas?
John S Bevan

Nat Clin Pract Endocrinol Metab· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Australian Study of HIV and Injecting Drug Use. Part I: prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities.
W M Loxley, M Phillips, S J Carruthers, J S Bevan

Drug Alcohol Rev· September 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Australian study of HIV and injecting Drug Use. Part II: predicting exposure to hepatitis C and hepatitis B.
S J Carruthers, W M Loxley, M Phillips, J S Bevan

Drug Alcohol Rev· September 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis